1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. INFLUX HEALTHTECH LTD.
Influx Healthtech Ltd.
NSE: INFLUX

Influx Healthtech Live Share Price Today, Share Analysis and Chart

aboutInflux Healthtech Ltd. is a contract development and manufacturing organization (CDMO) specializing in nutraceuticals, cosmetics, ayurvedic, and veterinary products. The company operates as a key manufacturing partner for various healthcare and perso... Read More
Ask AI about Influx Healthtech
264.503.70(1.42%)

54.90% Gain from 52W Low

3,600
NSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting
The next board meeting for Influx Healthtech is on 04 Nov 2026 for the purpose of Quarterly Results See details
Loading...
-
- / 100
50.7 / 100
Analyst Price Target
No estimates available

10

S

3

W

1

O

0

T

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

Medium rank

6Positive7Negative

46.2%Pass in checklist

045
55
100

Check P/E Buy Sell Zone

Neutral Zone

43.0 %    into P/E buy sell zone

% time spent below current P/E
020406080100
Strong upside potential
Gains already realized

Influx Healthtech Stock Price Analysis

Day Price Range

1.4% 1 Day return
264.5 (LTP)
254.7264.5
LowHigh

Week Price Range

2.9% 1 Week return
264.5 (LTP)
250275
LowHigh

Month Price Range

1.6% 1 Month return
264.5 (LTP)
240277
LowHigh

52 Week Price Range

41.5% 1 Year return
264.5 (LTP)
170.8315
LowHigh
View full Price History/Seasonality

Influx Healthtech Technical Analysis

Influx Healthtech EMA & SMA

Neutral0
4 bullish, 4 bearish
Bullish4
Bearish4
5 Day262.4
10 Day262.5
12 Day262.9
20 Day265.0
26 Day266.7
50 Day271.5
100 Day270.3
200 Day253.8

Influx Healthtech Delivery And Volume

Daily Avg. Delivery Volume %
30 Oct, 202683.3%
Week81.0%
Month74.5%

Influx Healthtech Active Candlesticks

Marubozu Uptrend Belt Hold Uptrend Closing Marubozu Uptrend Hikkake Uptrend Long Line Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Influx Healthtech Resistance and Support

261.23
Pivot
First Resistance267.8
Second Resistance271.0
Third Resistance277.6
First Support258.0
Second Support251.4
Third Support248.2
Day RSI48.4
Day MACD-3.8
Day MFI50
Day MACD Signal Line-4.4

Influx Healthtech Beta

1 Month0.5
1 Year1.2
3 Month0.9
3 Year-

Influx Healthtech Price Change Analysis

↑1.7%
Over 1 Month
LowHigh
240277
↓-10.8%
Over 3 Months
LowHigh
226309
↓-1.6%
Over 6 Months
LowHigh
226315
↑41.5%
Over 1 Year
LowHigh
170.8315
All Technicals →

Influx Healthtech Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Munir Abdul Ganee ChandniwalaPromoter16,142,10069.7 %
Kulbhushan ParasharPublic400,2001.7 %
Solidarity Micro Cap Emerging Leader AifDii406,8001.8 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Influx Healthtech Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
DEVI TRADERS LLPBulkSell11 Jul 2025176.39128,400NSE
ISHAAN TRADEFIN LLPBulkSell11 Jul 2025176.53139,200NSE
ISHAAN TRADEFIN LLPBulkPurchase11 Jul 2025176.76177,600NSE
DEVI TRADERS LLPBulkPurchase11 Jul 2025177.10110,400NSE
DEVI TRADERS LLPBulkSell10 Jul 2025175.14133,200NSE
DEVI TRADERS LLPBulkPurchase10 Jul 2025173.05129,600NSE
R K STOCKHOLDING (P) LTD.BulkSell09 Jul 2025151.56123,600NSE
DEVI TRADERS LLPBulkSell09 Jul 2025166.54145,200NSE
R K STOCKHOLDING (P) LTD.BulkPurchase09 Jul 20251501,200NSE
DEVI TRADERS LLPBulkPurchase09 Jul 2025166.92142,800NSE
All deals

Influx Healthtech Corporate Actions

Influx Healthtech Board Meetings

Influx Healthtech past and upcoming board meetings.

#Ex-Date
PurposeNotes
104 Nov 2026
Quarterly Results-
220 May 2026
Audited Results-
312 Nov 2025
Quarterly Results-
All Corporate Actions

Influx Healthtech - Company Profile

Influx Healthtech Management Structure

Influx Healthtech management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Mr. Ashish Ghanshyam ShahChief Financial Officer12.55Mar 26
Atul Kumar Ashok Kumar ShuklaCompany Secretary,Compliance Officer7.2Mar 26

Influx Healthtech Board of Directors

Influx Healthtech Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Munir Abdul Ganee ChandniwalaChairman & Managing Director84Mar 25
Shirin Munir Ahmed ChandniwalaWhole Time Director16Mar 25
Abdul Ganee Abdul Rasul ChandniwalaNon Executive Director-Mar 25
ASHOK KUMAR JAINIndependent Director-Mar 25
Vipul Balubhai PatelIndependent Director-Mar 25
Atul Kumar Ashok Kumar ShuklaCompany Sec. & Compli. Officer-Mar 25
Website: www.influxhealthtech.com

About the company - Business Profile

Influx Healthtech Ltd. is a contract development and manufacturing organization (CDMO) specializing in nutraceuticals, cosmetics, ayurvedic, and veterinary products. The company operates as a key manufacturing partner for various healthcare and personal care brands, providing end-to-end services from formulation to packaging. It maintains multiple manufacturing facilities designed to comply with international regulatory standards such as WHO-GMP and ISO certifications.

Key Points

  • Key Facts:
    • Founded: 2003 (as Influx Healthcare; later transitioned to Influx Healthtech).
    • Headquarters: Mumbai, Maharashtra.
    • Stock Listing: Listed on the NSE SME platform (Ticker: INFLUX).
    • Core Products: Tablets, capsules, syrups, powders, creams, and lotions across nutraceutical, herbal, and cosmetic categories.
  • Operations and Resources:
    • Operates multiple manufacturing units located in Palghar, Maharashtra.
    • Facilities are equipped for diverse dosage forms including solid orals (tablets/capsules), liquid orals, and semi-solids (creams/ointments).
    • The company maintains an in-house R&D and Quality Control laboratory to support product development and stability testing.
  • Market and Significance:
    • Primarily serves as a B2B partner for domestic and international brands in the wellness and personal care space.
    • Strategic importance lies in its ability to provide small to large-batch manufacturing for SME and large pharmaceutical players.
  • Sustainability and Innovation:
    • Focuses on "Clean Label" formulations in the cosmetic and nutraceutical segments, reducing synthetic additives.
    • Long-term goals include expanding into regulated export markets by upgrading facilities to meet US-FDA or EU-GMP standards.
  • Business Model:
    • Operates on a contract manufacturing model (CDMO). It is proficient in rapid formulation development and scaling up manufacturing for third-party brand owners.
  • Revenue Breakdown (Annual - FY2024-25 estimates based on available data):
    • By Segment:
      • Nutraceuticals: ~65%
      • Cosmetics & Personal Care: ~25%
      • Ayurvedic & Others: ~10%
    • By Geography:
      • Domestic (India): ~85%
      • Exports: ~15%
  • Key Products and Technology:
    • Specialized in Sustained Release (SR) and Delayed Release (DR) pellets for nutraceuticals.
    • Advanced manufacturing of Effervescent Tablets and high-protein supplement powders.
    • Utilization of automated filling and sealing lines for cosmetic tubes and bottles to ensure minimal human intervention.
  • Employee Count: The company employs approximately 150-200 personnel across its manufacturing and administrative functions.

References

  1. Annual Report Mar 2024
  2. Investor Presentation Nov 2025

Influx Healthtech FAQ

Influx Healthtech today is trading in the green, up by 1.42% at ₹264.5.
Influx Healthtech is currently trading up 1.42% on an intraday basis. In the past week the stock rose 2.92%. Stock has been down 10.78% in the past quarter and rose 41.48% in the past year. You can view this in the share price history/seasonality section.
Influx Healthtech is listed on NSE with the ticker INFLUX. It's currently trading on NSE at a share price of ₹264.5.
The market cap of Influx Healthtech is ₹612.33 Cr. as of Oct 30, 2026.
Influx Healthtech has never announced any dividend since the time of its listing on the NSE exchange.
Influx Healthtech has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.
Influx Healthtech reported ₹148.17 Cr. in revenue, ₹20.54 Cr. in net profit, and ₹31.19 Cr. in EBITD as of Mar 31, 2026 for FY25-26.
There are no analyst predictions for stock price target for Influx Healthtech.
The PE ratio of Influx Healthtech is 29.81 as of Oct 30, 2026.
The PB ratio of Influx Healthtech is 6.08 as of Oct 30, 2026.
There are no analyst reports for Influx Healthtech.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.
Ask AI
×